TrialJournal for immunotherapy of cancer2023

Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023.

Monika Joshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.